Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

bladder/antikancerogeno

Veza se sprema u međuspremnik
Stranica 1 iz 4036 rezultatima

SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
To provide a comprehensive overview and update of the Joint Société Internationale d'Urologie-International Consultation on Urological Diseases (SIU-ICUD) Consultation on Bladder Cancer for muscle-invasive presumably node-negative bladder cancer

[Bladder cancer: chemotherapy of advanced bladder cancer].

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Chemotherapy of advanced bladder cancer aims to destroy all the cancer cells in the host. For this purpose the most suitable and effective anticancer agents should be chosen. There have been many methods to select the anti-cancer drugs: sensitivity test. However, no reliable tests are available. We

Bladder cancer. Treatments improving.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se

Bladder cancer: Outpatient laser ablation is an option for localized bladder cancer treatment.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se

Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND The aim of this study is to comparatively elucidate the underlying molecular pathways and clinicopathological criteria in schistosomal bladder tumor (SBT) versus non-schistosomal bladder tumor (NSBT). METHODS This study explored the role of p53, p16, bcl-2, ki-67, c-myc, Rb and EGFR, by

Antitumor effects of bladder cancer-specific adenovirus carrying E1A-androgen receptor in bladder cancer.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
The high frequency of recurrence and poor survival rate of bladder cancer demand exploration of novel strategies. Gene therapy via adenovirus has shown promising potential for the treatment of tumors. We constructed a bladder cancer-specific adenovirus carrying E1A-androgen receptor (AR) under the

[Studies of anticancer drugs adhering to bladder mucosa for the treatment of bladder cancer].

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se

Superficial bladder cancer--treatment approach.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se

[A clinical survey of advanced bladder cancer: treatment of advanced and non-resectable bladder cancer].

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Sixty-three patients with advanced cancer of more than T3b and/or non-resectable bladder cancer who were treated at Kanazawa University Hospital from January 1982 to June 1990 were analyzed with regard to treatment and prognosis. Thirty-one of the 63 patients had non-resectable bladder cancer; T3b
To determine the optimal use of chemotherapy in the neoadjuvant, adjuvant, and metastatic setting in patients with advanced urothelial cell carcinoma, a consensus conference was convened by the World Health Organization (WHO) and the Société Internationale d'Urologie (SIU) to critically review the

[Innovations in superficial bladder cancer treatments].

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Bladder cancer treatment is a challenge for both urologists and oncologists. Particularly during these last years many changes have been made in the management of superficial bladder cancer. In the case of superficial bladder cancer, intravesical instillation of chemo/immunotherapeutic agents after

Bladder Sparing Landscape for Bacillus Calmette-Guérin Unresponsive Bladder Cancer

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Purpose of review: The treatment of bacillus Calmette-Guérin (BCG) unresponsive disease remains a challenge for urooncologists. The search for effective conservative treatments is ongoing and several new agents have been recently tested for this purpose. The aim of
OBJECTIVE Combined modality therapy has become the standard oncologic approach to achieve organ preservation in many malignancies. METHODS Although radical cystectomy has been considered as standard treatment for invasive bladder carcinoma in the United States, good results have been recently
Bladder cancer remains a difficult management problem, because of the high recurrence rate or the functional disorder of bladder post radical cystectomy. The autologous tissue engineering techniques have been advanced enough to reconstruct functional bladders for patients with myelomeningocele, but

Bladder cancer treatment: optimize, don't compromise.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Pridružite se našoj
facebook stranici

Najkompletnija baza ljekovitog bilja potpomognuta znanošću

  • Radi na 55 jezika
  • Biljni lijekovi potpomognuti znanošću
  • Prepoznavanje bilja slikom
  • Interaktivna GPS karta - označite bilje na mjestu (uskoro)
  • Pročitajte znanstvene publikacije povezane s vašom pretragom
  • Pretražite ljekovito bilje po učincima
  • Organizirajte svoje interese i budite u toku s istraživanjem vijesti, kliničkim ispitivanjima i patentima

Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Svi podaci temelje se na objavljenim znanstvenim istraživanjima

Google Play badgeApp Store badge